ALB and Hypoalbuminemia: Finally, although hypoalbuminemia has been demonstrated to be a risk factor of polymyxin AKI, hypoalbuminemia correction by administering exogenous albumin with the hope of preventing or mitigating nephrotoxicity has no clinical data so far and it is not advisable.